INTRODUCTION AND HYPOTHESIS: This prospective randomized study aimed to compare the safety and efficacy of the TVT-Secur (TVT-S) with the trans vaginal obturator tape (TVT-O) for the treatment of stress urinary incontinence. METHODS: We set out to enroll 136 patients in our study. 106 patients with stress urinary incontinence were randomized to either the TVT-S (n = 56) or TVT-O (n = 50) procedure. Patients were evaluated postoperatively at 2 months and 1 year. Our primary outcome was objective cure measured by the cough test. Secondary outcomes of subjective symptoms, questionnaires, pain scores, complications, and urodynamic studies were also included. Statistical analysis was by Chi-squared, Kruskal-Wallis, Wilcoxon, and Fisher's exact tests as appropriate. P values of <0.05 were considered significant. RESULTS:Objective cure rates were better for TVT-O compared with TVT-S at 1 year (86 % and 63 % respectively, p = 0.01). Subjective cure rates were 88 % for TVT-O and 63 % for TVT-S. Quality of life scores through questionnaires improved in both groups and were not statistically different. Initial post-operative groin pain was more prevalent in the TVT-O group; however, this resolved quickly with time. CONCLUSION:TVT-O was superior to TVT-S in the objective cure of stress urinary incontinence at 1-year follow-up.
RCT Entities:
INTRODUCTION AND HYPOTHESIS: This prospective randomized study aimed to compare the safety and efficacy of the TVT-Secur (TVT-S) with the trans vaginal obturator tape (TVT-O) for the treatment of stress urinary incontinence. METHODS: We set out to enroll 136 patients in our study. 106 patients with stress urinary incontinence were randomized to either the TVT-S (n = 56) or TVT-O (n = 50) procedure. Patients were evaluated postoperatively at 2 months and 1 year. Our primary outcome was objective cure measured by the cough test. Secondary outcomes of subjective symptoms, questionnaires, pain scores, complications, and urodynamic studies were also included. Statistical analysis was by Chi-squared, Kruskal-Wallis, Wilcoxon, and Fisher's exact tests as appropriate. P values of <0.05 were considered significant. RESULTS: Objective cure rates were better for TVT-O compared with TVT-S at 1 year (86 % and 63 % respectively, p = 0.01). Subjective cure rates were 88 % for TVT-O and 63 % for TVT-S. Quality of life scores through questionnaires improved in both groups and were not statistically different. Initial post-operative groin pain was more prevalent in the TVT-O group; however, this resolved quickly with time. CONCLUSION:TVT-O was superior to TVT-S in the objective cure of stress urinary incontinence at 1-year follow-up.
Authors: Maria Andrada Hamer; Per-Göran Larsson; Pia Teleman; Christina Eten Bergqvist; Jan Persson Journal: Int Urogynecol J Date: 2012-06-16 Impact factor: 2.894
Authors: Lekha S Hota; Katherine Hanaway; Michele R Hacker; Anthony Disciullo; Eman Elkadry; Patricia Dramitinos; Alexander Shapiro; Tanaz Ferzandi; Peter L Rosenblatt Journal: Female Pelvic Med Reconstr Surg Date: 2012 Jan-Feb Impact factor: 2.091
Authors: Piet Hinoul; Harry A M Vervest; Jan den Boon; Pieter L Venema; Marielle M Lakeman; Alfredo L Milani; Jan-Paul W R Roovers Journal: J Urol Date: 2011-02-22 Impact factor: 7.450
Authors: G Ghoniem; E Stanford; K Kenton; C Achtari; R Goldberg; T Mascarenhas; M Parekh; K Tamussino; S Tosson; G Lose; E Petri Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2007-11-17
Authors: Burhan Coskun; Rebecca S Lavelle; Feras Alhalabi; Gary E Lemack; Philippe E Zimmern Journal: Int Urogynecol J Date: 2014-10-23 Impact factor: 2.894
Authors: Sue Ross; Selphee Tang; Jane Schulz; Magnus Murphy; Jose Goncalves; Stephen Kaye; Lorel Dederer; Magali Robert Journal: BMC Res Notes Date: 2014-12-22
Authors: Jacek K Szymański; Kornelia Zaręba; Grzegorz Jakiel; Aneta Słabuszewska-Jóźwiak Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-04-29 Impact factor: 1.195